| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69a3ba7b54e6c69f506fc64a4d49a985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7cf789d3647a01d2098d4ed45f6aab15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b49eeebcd6bac40832bcb2b5c165cb2a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-205 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096 |
| filingDate |
2011-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e71d31d023484cba6cb4788917fd71d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d6dd76a60db6a6e7eca0ab83b186947 |
| publicationDate |
2014-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8778949-B2 |
| titleOfInvention |
1-(2-phenoxymethylphenyl)piperazine compounds |
| abstract |
The invention relates to compounds of formula I: n nwhere a, and R 1 through R 6 are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin and norepinephrine reuptake inhibitors. The invention also relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723900-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10206913-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10946007-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441579-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9675599-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10034870-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10722504-B2 |
| priorityDate |
2010-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |